Breaking Finance News

A statement released earlier today by Zacks Investment Research about Health Insurance Innovations Inc (NASDAQ:HIIQ) raises the target price to $27.00

Yesterday Health Insurance Innovations Inc (NASDAQ:HIIQ) traded 5.14% higher at $23.60. HIIQ’s 50-day average is $30.59 and its two hundred day average is $22.78. With the last stock price close up -1.21% from the 200-day moving average, compared to the S&P 500 which has increased 0.04% over the same time. 1,533,609 shares of the stock were exchanged, up from an average trading volume of 795,427

Health Insurance Innovations Inc (NASDAQ:HIIQ) had its target price raised to $27.00 by Zacks Investment Research in a report released 06/21/2017. The new target price indicates a possible upside of 0.14% based on the company's last stock close price.

See Chart Below

Health Insurance Innovations Inc (NASDAQ:HIIQ)

Health Insurance Innovations Inc has a PE ratio of 18.20 with a one year low of $4.00 and a one year high of $37.38 Health Insurance Innovations Inc’s market capitalization is presently $0.

In addition to Zacks Investment Research reporting its stock price target, a total of 1 brokerage has issued a ratings update on the company. The average stock price target is $9.00 with 0 brokerages rating the stock a strong buy, 0 brokerages rating the stock a buy, 0 brokerages rating the stock a hold, 0 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.

Brief Synopsis On Health Insurance Innovations Inc (NASDAQ:HIIQ)

Health Insurance Innovations, Inc. is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP. The Company's STM plans are provided up to six months, 11 months, or 364 days of health insurance coverage with a range of deductible and copay levels. Individual major medical (IMM) plans cover prescription drugs, pre-existing conditions and preventive care, while STM plans provide optional coverage for prescription drugs.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *